Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

about

Neoadjuvant-intensified treatment for rectal cancer: time to change?

P2860

Q34743672-A5632782-F1D7-42FE-86AF-25DA8CD0A189

P2860

Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

Item

http://www.wikidata.org/entity/Q44896094

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@en

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@nl

type

Item

label

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@en

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@nl

prefLabel

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@en

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy.

@nl

P1476

Incidence of thromboembolic ev ...... neoadjuvant chemoradiotherapy

@en

P2093

Errico Orsi

http://www.w3.org/2001/XMLSchema#string

Francesca de Felice

http://www.w3.org/2001/XMLSchema#string

Isabella Verdinelli

http://www.w3.org/2001/XMLSchema#string

Nicola Raffetto

http://www.w3.org/2001/XMLSchema#string

Silvia Mezi

http://www.w3.org/2001/XMLSchema#string

Vincenzo Tombolini

http://www.w3.org/2001/XMLSchema#string

P2860

Thromboembolism in patients with advanced gastroesophageal cancer treated with anthracycline, platinum, and fluoropyrimidine combination chemotherapy: a report from the UK National Cancer Research Institute Upper Gastrointestinal Clinical Studies Gr

Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial.

Chemotherapy-induced thrombosis.

Development and validation of a predictive model for chemotherapy-associated thrombosis.

Late adverse effects of radiation therapy for rectal cancer - a systematic overview.

Emerging risk stratification approaches to cancer-associated thrombosis: risk factors, biomarkers and a risk score.

Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience.

Comparison of two neoadjuvant chemoradiotherapy regimens for locally advanced rectal cancer: results of the phase III trial ACCORD 12/0405-Prodige 2.

Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer.

P304

187-190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/0284186X.2012.689114

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Federica Morano

Daniela Musio

P577

2012-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225277040

http://www.w3.org/2001/XMLSchema#string

P698

22671575

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy

thromboembolism

Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

about

P2860

P2860

Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921